Sabreen Mkalaluh, Marcin Szczechowicz, Saeed Torabi, Bastian Schmack, Anton Sabashnikov, Bashar Dib, Matthias Karck, Alexander Weymann
Department of Cardiac Surgery, Heart and Marfan Center – University of Heidelberg, Heidelberg, Germany
Med Sci Monit 2017; 23:6201-6209
The aim of this study was to investigate the clinical presentation, operative data, and early and late outcomes of a large patient cohort undergoing surgical treatment for cardiac tumors in our institution.
MATERIAL AND METHODS: A total of 181 patients underwent surgery because of suspected cardiac tumor in our institution between 1998 and 2016. In 162 cases, the diagnosis was confirmed postoperatively and these patients were included in this study. Preoperative baseline characteristics, operative data, and postoperative early and long-term outcomes were analyzed.
RESULTS: Mean age at presentation was 56.6±17.6 years, and 95 (58.6%) patients were female. There were 126 (77.8%) patients with benign cardiac tumors, while the remaining patients had malignant tumors (primary and metastasized). The mean follow-up time was 5.2±4.7 years. The most frequent histologically verified tumor type was myxoma (63%, n=102). In terms of malignant tumors, various types of sarcomas presented most primary malignant cardiac tumors (7.4%, n=12). The mean ICU length of stay was 1.7±2.2 days and overall in-hospital mortality was 3.1% (n=5). Frequent postoperative complications included mediastinal bleeding (5.8%, n=9), wound infection (1.3%, n=2), acute renal failure (5.6%, n=9), and major cerebrovascular events (n=7, 4.6%). The overall cumulative survival after cardiac tumor resection was 94% at 30 days, 85% at 1 year, 72% at 5 years, and 59% at 15 years.
CONCLUSIONS: Surgical treatment of cardiac tumors is a safe and highly effective strategy associated with good early and long-term outcomes.
Keywords: Cardiac Surgical Procedures, Heart Neoplasms, Patient Outcome Assessment